Drugs to combat HIV are about to become cheaper in developing countries. The
multinationals Glaxo Wellcome and Hoffmann-La Roche will supply drugs at cut
rates to Uganda, Côte d’Ivoire, Chile and Vietnam in a two-year pilot
initiative organised by the Joint UN Programme on HIV/AIDS. Virco, a Belgian
diagnostics company, will train local technicians to screen patients to work out
which drugs to use. “We want to demonstrate that it is workable and
sustainable,” says Joseph Saba, the initiative’s coordinator. The extent of the
discounts is still being worked out.
More from New Scientist
Explore the latest news, articles and features
Popular articles
Trending New Scientist articles
1
If you aren't terrified by this heatwave, you should be
2
Remote-controlled cockroach swarm can now breathe underwater
3
We’ve uncovered a master gene that switches on human development
4
Humans sleep the least of all apes – is it the secret to our success?
5
Our verdict on The Selfish Gene: An unpopular piece of popular science
6
Where, when and how to watch the 2026 solar eclipse
7
Ancient human DNA found on cave art for the first time
8
The best sci-fi novel in 2026 so far – plus 6 other great reads
9
Europe’s heatwave is the hottest and most humid ever
10
Neuroscience can't tell us the way to govern people's brains
